Name: MiMedx Group, Inc. (MDXG) Financial Statements
Creator: FinSpry

MiMedx Group Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

MiMedx Group, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	348.88	321.48	267.84	242.02	248.23
Cost of Revenue	60.07	54.63	48.32	39.63	39.33
Gross Profit	288.81	266.84	219.53	202.39	208.90
Operating Expenses
Research & Development	12.34	12.67	12.70	9.93	11.72
Selling, General & Administrative	216.39	216.30	220.85	198.64	240.49
Operating Expenses	229.50	229.73	234.25	209.39	253.28
Operating Income	59.31	37.12	-14.73	-7.00	-44.37
Other Income/Expense
Interest Income	2.93	0.12	0.03	0.00	0.33
Interest Expense	-3.94	-6.58	-5.05	-4.98	-8.27
Other Income/Expense	-0.57	-0.03	0.00	-0.02	0.00
Income
Income Before Tax	57.29	30.63	-19.75	-12.05	-61.54
Income Tax Expense	15.30	-36.81	0.21	0.25	-12.26
Net Income	42.42	58.23	-30.20	-10.29	-49.28
Net Income - Continuous Operations	42.42	67.44	-19.95	-12.30	0.00
Net Income - Discontinued Operations	0.42	-9.21	-10.24	0.00	0.00
EBITDA	65.35	40.54	-10.68	-1.82	-37.52
EBIT	59.31	37.12	-14.73	-7.00	-44.37
Depreciation & Amortization	6.04	3.43	4.05	5.18	6.86
Earnings Per Share
Basic EPS	-	-	-	-	-1.00
Diluted EPS	-	-	-	-	-1.00
Basic Shares Outstanding	146.98	116.50	112.91	110.35	108.26
Diluted Shares Outstanding	149.05	145.96	112.91	110.35	108.26